PEAR
Pear Therapeutics, Inc. Class A Common Stock
PEAR
PEAR
Delisted
PEAR was delisted on the 18th of April, 2023.
40 hedge funds and large institutions have $118M invested in Pear Therapeutics, Inc. Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
69% less capital invested
Capital invested by funds: $385M → $118M (-$267M)
Holders
40
Holding in Top 10
4
Calls
$676K
Puts
–
Top Buyers
| 1 | +$539K | |
| 2 | +$360K | |
| 3 | +$326K | |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$321K |
| 5 |
JP Morgan Chase
New York
|
+$140K |
Top Sellers
| 1 | -$983K | |
| 2 | -$624K | |
| 3 | -$589K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$388K |
| 5 |
Squarepoint
New York
|
-$257K |